Delos Wealth Advisors’s Encompass Health EHC Stock Holding History

Delos Wealth Advisors’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-91	Closed	-$5K	–	315
2021 Q4	$5K	Buy	+91	New	+$4.7K	﹤0.01%	301

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Delos Wealth Advisors's EHC Position: Q1 2022 in Review

Delos Wealth Advisors sold out of Encompass Health (EHC) in Q1 2022, closing a stake of 91 shares — an estimated $5K sold.

Delos Wealth Advisors first reported a position in EHC in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 406 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

Delos Wealth Advisors reported no remaining Encompass Health position as of Q1 2022 after selling out during the quarter.
Delos Wealth Advisors sold 91 Encompass Health shares in Q1 2022, an estimated $5K.
Delos Wealth Advisors first reported a position in Encompass Health in Q4 2021 and held it in 1 quarter.
Delos Wealth Advisors's Encompass Health position peaked at $5K in Q4 2021.
406 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Delos Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.